Ability of reconstituted high density lipoproteins to inhibit cytokine- induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells

Journal of Lipid Research

Volumn 40, Issue 2, 1999, Pages 345-353

  Baker, Paul W ^a,b   Rye, Kerry Anne ^a,b   Gamble, Jennifer R ^b   Vadas, Mathew A ^b   Barter, Philip J ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Apolipoproteins; Endothelial cells; Phospholipids; Reconstituted HDL; VCAM 1

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL ESTER; CYTOKINE; HIGH DENSITY LIPOPROTEIN; LIPID; PHOSPHOLIPID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; APOLIPOPROTEIN A1;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPID COMPOSITION; PARTICLE SIZE; PRIORITY JOURNAL; UMBILICAL VEIN; ANALYSIS OF VARIANCE; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; LIPID BILAYER; METABOLISM; RABBIT; VASCULAR ENDOTHELIUM;

ANALYSIS OF VARIANCE; ANIMALS; APOLIPOPROTEIN A-I; CHOLESTEROL ESTERS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; LIPID BILAYERS; LIPOPROTEINS, HDL; PARTICLE SIZE; PHOSPHOLIPIDS; RABBITS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032908549     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Gordon, D. J., and B. M. Rifkind. 1989. High-density lipoprotein: The clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
2. Bruce, C., and A. R. Tall. 1995. Cholesteryl ester transfer protein, reverse cholesterol transport, and atherosclerosis. Curr. Opin. Lipidol. 6: 306-311.
3. Quintao, E. C. R. 1995. Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation? Atherosclerosis. 116: 1-14.
4. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
5. Mackness, M. I., and P. N. Durrington. 1995. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 115: 243-253.
6. Cockerill, G. W., K-A. Rye, J. R. Gamble, M. A. Vadas, and P. J. Barter. 1995. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15: 1987-1994.
7. Ashby, D. T., K-A. Rye, M. A. Clay, M. A. Vadas, J. R. Gamble, and P.J. Barter. 1998. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18: 1450-1455.
8. Li, H., M. I. Cybulsky, M. A. Gimbrone, and P. Libby. 1993. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 13: 197-204.
9. Davies, M. J., J. L. Gordon, A. J. H. Gearing, R. Pigott, N. Woolf, D. Katz, and A. Kyriakopoulos. 1993. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J. Pathol. 171: 223-229.
10. Peter, K., P. Nawroth, C. Condradt, T. Nordt, T. Weiss, M. Boehme, A. Wunsch, J. Allenberg, W. Kubler, and C. Bode. 1997. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intracellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler. Thromb. Vasc. Biol. 17: 505-512.
11. Calabresi, L., G. Franceschini, C. R. Sirtori, A. De Palma, M. Saresella, P. Ferrante, and D. Taramelli. 1997. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins. Biochem. Biophys. Res. Commun. 238: 61-65.
12. Moudry, R., M. O. Spycher, and J. E. Doran. 1997. Reconstituted high density lipoprotein modulates adherence of polymorphonuclear leukocytes to human endothelial cells. Shock. 7: 175-181.
13. Osborne, J. C. 1986. Delipidation of plasma lipoproteins. Methods Enzymol. 128: 213-222.
14. Rye, K-A., K. H. Garrety, and P. J. Barter. 1993. Preparation and characterization of spheroidal, reconstituted high-density lipoproteins with apolipoprotein A-I only or with apolipoprotein A-I and A-II. Biochim. Biophys. Acta. 1167: 316-325.
15. Rye, K-A., N. J. Hime, and P. J. Barter. 1997. Evidence that cholesteryl ester transfer protein-mediated reductions in reconstituted high density lipoprotein size involve particle fusion. J. Biol. Chem. 272: 3953-3960.
16. Rye, K-A., N. J. Hime, and P. J. Barter. 1996. The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins. J. Biol. Chem. 271: 4243-4250.
17. Jonas, A. 1986. Reconstitution of high-density lipoproteins. Methods Enzymol. 128: 553-582.
18. Matz, C. E., and A. Jonas. 1982. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257: 4535-4540.
19. Rye, K-A., and P. J. Barter. 1994. The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins. J. Biol. Chem. 269: 10298-10303.
20. Rye, K-A., N.J. Hime, and P.J. Barter. 1995. The influence of cholesteryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins. J. Biol. Chem. 270: 189-196.
21. Wall, R. T. 1978. Factors influencing endothelial cell proliferation in vitro. J. Cell Physiol. 96: 203-213.
22. Oram, J. F., and S. Yokoyama. 1996. Apolipoprotein-mediated removal of cellular cholsterol and phospholipids. J. Lipid Res. 37: 2473-2491.
23. Johnson, W. J., F. H. Mahlberg, G. H. Rothblat, and M. C. Phillips. 1991. Cholesterol transport between cells and high-density lipoproteins. Biochim. Biophys. Acta. 1085: 273-298.
24. de la Llera Moya, M., V. Atger, J. L. Paul, N. Fournier, N. Moatti, P. Giral, K. E. Friday, and G. Rothblat. 1994. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler. Thromb. 14: 1056-1065.
25. Barkia, A., P. Puchois, N. Ghalim, G. Torpier, R. Barbaras, G. Ailhaud, and J. C. Fruchart. 1991. Different role of apolipoprotein A-I-containing particles in cholesterol efflux from adipose cells. Atherosclerosis. 87: 135-146.
26. Oikawa, S., A. J. Mendez, J. F. Oram, E. L. Bierman, and M. C. Cheung. 1993. Effects of high-density lipoprotein particles containing apoA-I with or without apoA-II, on intracellular cholesterol efflux. Biochim. Biophys. Acta 1165: 327-334.
27. Hara, H., and S. Yokoyama. 1991. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266: 3080-3086.
28. Yancey, P. G., J. K. Bielicki, W. J. Johnson, S. Lund-Katz, M. N. Palgunachari, G. M. Anantharamaiah, J. P. Segrest, M. C. Phillips, and G. H. Rothblat. 1995. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34: 7955-7965.
29. Li, Q., H. Czarnecka, and S. Yokoyama. 1995. Involvement of a cellular surface factor(s) in lipid-free apolipoprotein-mediated cellular cholesterol efflux. Biochim. Biophys. Acta. 1259: 227-234.
30. Sviridov, D., L. E. Pyle, and N. Fidge. 1996. Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants. J. Biol. Chem. 271: 33277-33283.
31. DeLamatre, J., G. Wolfbauer, M. C. Phillips, and C., H. Rothblat. 1986. Role of apolipoproteins in cellular cholesterol efflux. Biochim. Biophys. Acta. 875: 419-428.
32. Davidson, W. S., K. L. Gillotte, S. Lund-Katz, W. J. Johnson, G. Rothblat, and M. C. Phillips. 1995. The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J. Biol. Chem. 270: 5882-5890.
33. Jonas, A., K. E. Kezdy, and J. Hefele Wald. 1989. Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J. Biol. Chem. 264: 4818-4824.
34. Sparks, D. L., W. S. Davidson, S. Lund-Katz, and M. C. Phillips. 1993. Effect of cholesterol on the charge and structure of apolipopiotein A-I in recombinant high density lipoprotein particles. J. Biol. Chem. 268: 23250-23257.
35. Mendez, A. J., G. M. Anantharamaiah, J. P. Segrest, and J. F. Oram. 1994. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94: 1698-1705.
36. Bond, H. M., G. Morrone, S. Venuta, and K. E. Howell. 1991. Characterization and purification of proteins which bind high-density lipoprotein. A putative cell-surface receptor, Biochem. J. 279: 633-641.
37. Sviridov, D. D., A. Y. Misharin, I. G. Safonova, N. G. Bushmakina, V. S. Repin, and V. N. Smirnov. 1988. Binding of partially reassembled high-density lipoprotein to isolated human small intestine epithelial cells. Effect of lipid composition. Biochim. Biophys. Acta. 963: 119-125.
38. Jonas, A., J. H. Wald, K. L. Harms Toohill, E. S. Krul, and K. E. Kezdy. 1990. Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. J. Biol. Chem. 265: 22123-22129.
39. Sparks, D. L., S. Lund-Katz, and M. C. Phillips. 1992. The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. J. Biol. Chem. 267: 25839-25847.
40. Sparks, D. L., M. C. Phillips, and S. Lund-Katz. 1992. The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. J. Biol. Chem. 267: 25830-25838.
41. Fruchart, J. C., C. De Geteire, B. Delfly, and G. R. Castro. 1994. Apolipoprotein A-I-containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis risk. Atherosclerosis. 110: S35-S39.
42. Duverger, N., H. Kruth, F. Emmanuel, J-M. Caillaud, C. Viglietta, G. Castro, A. Taileux, C. Eleven, J. C. Fruchart, L. M. Houdebine, and P. Denefle. 1996. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation. 94: 713-717.
43. Warden, C. H., C. C. Hedrick, J. H. Qiao, L. W. Castellani, and A. I., Lusis. 1993. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 261: 469-472.
44. Pastzy, C., N. Maeda, J. Verstuyft, and E. M. Rubin. 1994. Apolipoprotein A-I transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94: 899-903.
45. Rubin, E. M., R. M. Krauss, E. A. Spangler, J. G. Verstuyft, and S. M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature. 353: 265-267.
46. Schultz, J. R., J. G,. Verstuyft. E. L. Gong, A. V. Nichols, and E. M. Rubin. 1993. Protein composition determines the anti-atherogenic properties of HDL. in transgenic mice. Nature. 365: 762-764.
47. Klein, C., H. Kohler, F. Bittinger, M. Wagner, I. Hermanns, K. Grant, J. C. Lewis, and C. J. Kirkpatrick. 1994. Comparative studies on vascular endothelium in vitro. I. Cytokine effects on the expression of adhesion molecules by human umbilical vein, saphenous vein and femoral artery endothelial cells. Pathobiology. 62: 199-208.